home / stock / vynt / vynt news


VYNT News and Press, Vyant Bio Inc. From 09/04/23

Stock Information

Company Name: Vyant Bio Inc.
Stock Symbol: VYNT
Market: NASDAQ
Website: vyantbio.com

Menu

VYNT VYNT Quote VYNT Short VYNT News VYNT Articles VYNT Message Board
Get VYNT Alerts

News, Short Squeeze, Breakout and More Instantly...

VYNT - Expected US Company Earnings on Monday, September 4th, 2023

American Bio Medica Corp. (ABMC) is expected to report for Q1 2024 Fonar Corporation (FONR) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q2 2023 QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 BIMI International Medical...

VYNT - Expected earnings - Vyant Bio Inc.

Vyant Bio Inc. (VYNT) is expected to report for Q2 2023

VYNT - AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio's StemoniX Assets

AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio's StemoniX Assets PR Newswire —Combines Three Leading Human Biomimetic Organoid Platform Technologies for Neurological Drug Discovery— —AxoSim Gains microBrain™ Intellectual...

VYNT - Vyant slumps ~10% on last trading day on Nasdaq; delisting part of cash saving plan

2023-05-12 08:39:35 ET Vyant Bio ( NASDAQ: VYNT ) expects to delist its common shares from Nasdaq on/around May 14 and the shares are anticipated to be quoted on the Pink Open Market under the same symbol around May 15. The last day of trading on Nasdaq will be today (May 12)....

VYNT - Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC Deregistration

CHERRY HILL, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is a biotechnology company that incorporates innovative biology and data science to improve drug discovery for complex neurodevelopmental and neurodegener...

VYNT - Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC Deregistration

CHERRY HILL, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is a biotechnology company that incorporates innovative biology and data science to improve drug discovery for complex neurodevelopmental and neurodegener...

VYNT - What Is Going on With In8bio (INAB) Stock Today?

2023-04-25 09:36:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In8bio (NASDAQ: INAB ) stock is on the move Tuesday as investors react to a recent rally and additional news from the biotechnology company. First off, investors will note t...

VYNT - Why Is TRACON Pharma (TCON) Stock Down 51% Today?

2023-04-25 09:11:29 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips TRACON Pharmaceuticals (NASDAQ: TCON ) stock is falling on Tuesday following an update on a legal battle with I-Mab (NASDAQ: IMAB ). The bad news for TCO...

VYNT - Why Is Vyant Bio (VYNT) Stock Down 35% Today?

2023-04-25 08:53:54 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Vyant Bio (NASDAQ: VYNT ) stock is taking a beating on Tuesday after the biotechnology company announced plans to delist its shares . According to a press release, the c...

VYNT - Vyant Bio announces voluntary Nasdaq delisting and SEC de-registration

2023-04-24 17:21:48 ET Vyant Bio ( NASDAQ: VYNT ) said its board had decided to voluntarily delist its securities from The Nasdaq Capital Market. The company said it had begun delisting and filed a Form 25 with the Securities and Exchange Commission, which is expected to becom...

Previous 10 Next 10